Logo-jre

   
J Ren Endocrinol. 2022;8: e19064 | Published on: 2022 Oct 15. doi: 10.34172/jre.2022.19064

Original Article

Effect of nanocurcumin on serum levels of betatrophin and irisin in patients with metabolic syndrome; a clinical trial

Hamid Gholami 1 ORCID, Nejat Kheiripour 2 ORCID, Mehdi Bahmani 3 ORCID, Akram Ranjbar 4 ORCID, Zahra Khodamoradi 5 ORCID, Shiva Borzouei 6 * ORCID

Cited by CrossRef: 2

1- Ataei M, Gumpricht E, Kesharwani P, Jamialahmadi T, Sahebkar A. Recent advances in curcumin-based nanoformulations in diabetes. Journal of Drug Targeting. 2023;31(7):671 [Crossref]
2- Abd El-Hack M, Alazragi R, Khafaga A, Qadhi A, Ghafouri K, Azhar W, Alqhtani A, Khojah H, Swelum A, Świątkiewicz S. The relationship between dietary curcumin supplementation and metabolic syndrome – A Review. 2024;24(2):413 [Crossref]